Global Antidepressant Drugs Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027
MarketResearch.biz delivers in-depth insights on the global antidepressant drugs market in its upcoming report titled, “Global Antidepressant Drugs Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global antidepressant drugs market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global antidepressant drugs market report has been segmented on the basis of disorder, product, and region.
Antidepressants are category of drugs used to treat symptoms of depression. Antidepressants are available in various forms, most of them work by impacting bound neurotransmitters in the brain such as serotonin and norepinephrine. However, if the drug does not relieve symptoms it may cause adverse effect on the body. Once an antidepressant is selected a trial of adequate doses for at least 8–12 weeks is recommended. Spectrophotometric and chromatographic methods have been developed to determine the antidepressant drug sulpiride (SUL). There are many antidepressant drugs available such as selective serotonin re-uptake inhibitors (SSRIs), serotonin and norepinephrine re-uptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants (TCAs), tetracyclic antidepressants, and serotonin receptor modulators.
Unhealthy lifestyle with increasing stress level among adults and prevalence of depression among geriatric population are major factors driving growth of the global antidepressant drugs market. In addition, rising awareness related to conditions such as generalized anxiety disorder, agitation, obsessive compulsive disorders (OCD) is expected to support growth of the global antidepressant drugs market.
However, potential side effects of antidepressant drugs such as nausea, vomiting, dizziness, headache, irritability, sleep disturbance, nightmares, psychosis, and seizures is a major factor restraining growth of the global antidepressant drugs market.
North America market is expected to account for highest share in the global antidepressant drugs market in terms of revenue, owing to increasing incidences of generalized anxiety disorder, agitation, obsessive compulsive disorders (OCD). In addition, presence of prominent players operating in the market in this region is another factor contributing to growth of target market in North America. Europe market is projected to account for second-largest revenue share in the global market, followed by markets in Asia Pacific, Latin America, and Middle East & Africa respectively. The market in Asia Pacific is projected to register highest CAGR in terms of revenue over the forecast period. This can be attributed to increasing disorders such as childhood enuresis and diabetic peripheral neuropathic pain in emerging economies in this region.
Global Antidepressant Drugs Market Segmentation:
- Major Depressive Disorder
- Obsessive-Compulsive Disorder
- Generalized Anxiety Disorder
- Panic Disorder
- Others (manic-depressive disorders and childhood enuresis)
- Tricyclic Antidepressants
- Selective Serotonin Reuptake Inhibitors
- Serotonin-norepinephrine reuptake Inhibitors
- Monoamine oxidase inhibitors
- Serotonin antagonist and reuptake inhibitors
- Others (Lithium Salts and Tetracyclic antidepressants)
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2028 Revenue in US$
- Alkermes Plc
- Allergan Plc
- Bristol Myers Squibb Co.
- Eli Lilly and Co.
- GlaxoSmithKline Plc
- Lundbeck A/S
- Merck & Co., Inc.
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Co. Ltd.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!